Abstract:The assignment of diketone and keto‐enol signals of four 1,3‐dicarbonyl drug pre‐precursors, α‐phenylacetoacetamide (APAA), methyl α‐phenylacetoacetate (MAPA), ethyl α‐phenylacetoacetate (EAPA), and methyl 2‐(benzo[d][1,3]dioxol‐5‐yl)‐3‐oxobutanoate (MAMDPA), was achieved through 1D and 2D NMR. The diketo form was predominant for the vast majority of 1,3‐dicarbonyl drug precursors. The equilibrium of the keto‐enol tautomerism was affected by solvent polarity, type of substitution, and impurities in the sample. After the optimization of several key quantitative parameters, a qNMR method for 1,3‐dicarbonyl drug precursors was developed. The effective implementation of drug precursor legislation has driven the innovation and design of new alternative substances. The application of 1,3‐dicarbonyl precursors as alternative precursors for the synthesis of 1‐phenyl‐2‐propanone (P2P) and 3,4‐methylenedioxyphenyl‐2‐propanone (MDP2P) has created new challenges to legal control. Their 1,3‐dicarbonyl structure allows the precursors to exist as an equilibrium mixture of the tautomeric diketo and keto‐enolic forms during the nuclear magnetic resonance (NMR) analysis. In this study, the keto‐enol tautomerism of four 1,3‐dicarbonyl drug pre‐precursors, α‐phenylacetoacetamide (APAA), methyl α‐phenylacetoacetate (MAPA), ethyl α‐phenylacetoacetate (EAPA), and methyl 2‐(benzo[d][1,3]dioxol‐5‐yl)‐3‐oxobutanoate (MAMDPA) were investigated through NMR. One‐dimensional (1D) and 2D NMR were combined to assign signals for the diketo and keto‐enolic tautomers. Results showed that the keto‐enol tautomerism was solvent‐dependent but was also influenced by the substituent present in the molecule. Further, the analysis results indicated that majority of substances existed mainly in the diketo form. The enol‐keto equilibrium constant (Keq) was stable in dimethyl sulfoxide‐d6 and chloroform‐d, while unstable for some compounds in acetone‐d6 and deuterated methanol. The presence of impurities in the seized sample may disrupt the equilibrium between keto‐enol tautomers in 1,3‐dicarbonyl precursors. After the optimization of several key quantitative parameters, a quantitative NMR method for the quantification of 1,3‐dicarbonyl drug precursors were also developed to facilitate their quantitative analysis. This is the first study to investigate the keto‐enol tautomerism and quantification of 1,3‐dicarbonyl drug precursors by NMR, providing a new approach for structure analysis and quantification of new precursor analogues.

NMR Characteristics and Conformational Analysis of Oxiracetam

A Randomized Double-Blind Controlled Multicenter Study with Oxiracetam in Treatment of Organic Brain Syndrome

Molecular docking, spectroscopic studies and quantum calculations on nootropic drug

NMR Characteristics and Conformational Analysis of ( E ) -3- ( 4-hydroxyphenyl ) - 1 - ( piperidin- 1-yl )prop-2-en-l-one Derivatives

Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice.

1H NMR STUDY ON THE STEREOCHEMISTRY OF 1,3-OXAZINO[3,2-D][1,5] BENZODIAZEPINE-1-ONES

Raman and terahertz spectroscopical investigation of cocrystal formation process of piracetam and 3-hydroxybenzoic acid

(S)-Oxiracetam is the Active Ingredient in Oxiracetam That Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats

Study On The Spectroscopy Of (4r-Cis)-6-[2-[2-(4-Fluorophenyl)-5(Methylethyl)-3-Phenyl-4-(Phenylamino )-H-1-Pyrrole-1-Yl]-Ethyl]-2,2-Dimethyl-1,3-Dioxacyclohexyl-4-Acitic Acid Terbutyl Ester

Assignment of NMR Data and Conformational Analysis of Larotrectinib and Its Precursors

Structural Studies of Norditerpenoid Alkaloids: Conformation Analysis in Crystal and in Solution States

Nmr Studies of A Series of Shikimic Acid Derivatives

Development and Validation of a Chiral UPLC-MS/MS Method for Quantifying S-Oxiracetam and R-Oxiracetam in Human Plasma, Urine and Feces: Application to a Phase-I Clinical Pharmacokinetic Study

Exposing Hidden Alternative Conformations of Small Flexible Molecules in 2D NMR Spectroscopy Using 1H-15N HMBC

An NMR study on the keto‐enol tautomerism of 1,3‐dicarbonyl drug precursors

A clinical trial evaluating the efficacy and safety of oxiracetam in the treatment of patient with post-stroke cognitive impairment

Theoretical and NMR Investigations on the Conformations of ( − )-Meptazinol Hydrochloride in Solution

NMR-Based Chiral Discrimination of Bulky Amines with a 19F-Tagged NNO Pincer Complex.

Using HPLC to Analyze (S)-Oxiracetam and Four Related Substances in the Bulk Drug of (S)-Oxiracetam.

Organic NMR Crystallography: Enabling Progress for Applications to Pharmaceuticals and Plant Cell Walls

NMR, UV, FT-IR, FT-Raman spectra and molecular structure (monomeric and dimeric structures) investigation of nicotinic acid N-oxide: A combined experimental and theoretical study